MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.70387

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndrome.

Fleming Victoria L, Helsel Brian C, Ptomey Lauren T, Handen Benjamin L, Krinsky-McHale Sharon J, Hom Christy L, Zammit Matthew, Minhas Davneet, Luo Weiquan, Laymon Charles, Lee Joseph H, Lott Ira, Cohen Annie, Ances Beau M, Brickman Adam M, Pulsifer Margaret, Clare Isabel C H, Rosa H Diana, Lai Florencia, Harp Jordan, Schmitt Fredrick, Price Julie, Zaman Shahid H, Head Elizabeth, Mapstone Mark, Christian Bradley T, Okonkwo Ozioma, Hartley Sigan L, Alzheimer's Biomarkers Consortium–Down Syndrome

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

INTRODUCTION

Weight loss has been linked to early Alzheimer's disease (AD) pathology, possibly through metabolic dysregulation. We examined changes in body mass index (BMI) in relation to AD biomarkers (amyloid beta [Aβ] and tau) and cognitive decline in adults with Down syndrome (DS). We hypothesized that BMI decline would track with early AD pathology and cognitive decline.

METHODS

Adults with DS (N = 467; Mage = 43.67 ± 10.06) completed one to four data cycles (≈16 months apart). Linear mixed models examined BMI change over time by age, positron emission tomography (PET) Aβ and tau, and changes in memory and dementia symptoms.

RESULTS

BMI declined with age-by-time (β = -0.014, p = 0.002) and baseline PET Aβ-by-time (β = -0.005, p = 0.002). On average, BMI decline began in the early 40s and was related to decline in memory and overall cognitive functioning.

DISCUSSION: Weight loss is associated with the presence of Aβ and cognitive decline in adults with DS. Longitudinal studies need to clarify directionality and biological mechanisms.

HIGHLIGHTS: Adults with Down syndrome (DS) are at an elevated risk for Down Syndrome assocaited Alzheimer's disease (DSAD). On average, adults with DS experience body mass index (BMI) decline beginning in their early 40s. Positron emission tomography amyloid beta deposition is associated with greater decline in BMI in adults with DS. Across time, AD-related memory declines are associated with BMI decline. BMI decline should be part of DSAD screening tools, as it is an important part of DSAD clinical disease expression.

Для цитирования: Fleming Victoria L, Helsel Brian C, Ptomey Lauren T, Handen Benjamin L, Krinsky-McHale Sharon J, Hom Christy L, Zammit Matthew, Minhas Davneet, Luo Weiquan, Laymon Charles, Lee Joseph H, Lott Ira, Cohen Annie, Ances Beau M, Brickman Adam M, Pulsifer Margaret, Clare Isabel C H, Rosa H Diana, Lai Florencia, Harp Jordan, Schmitt Fredrick, Price Julie, Zaman Shahid H, Head Elizabeth, Mapstone Mark, Christian Bradley T, Okonkwo Ozioma, Hartley Sigan L, Alzheimer's Biomarkers Consortium–Down Syndrome. Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndrome.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. DOI: 10.1002/alz.70387.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.